PAUL Glaucoma Implant

Surgical Technique

PAUL Stability System by
Prof. Victor Koh1

Play Video

Paul Implantation Technique by
Prof. Keith Barton2

Play Video

Clinical Data

In a multi-center clinical study, a 62% reduction in IOP was observed 12 months after surgery. Similarly, glaucoma medications needed was reduced from 3.3 to 0.3 post-operatively*

Koh V, Chew P, Triolo G, et al. Treatment outcome using the PAUL glaucoma implant to control intraocular pressure in eye with refractory glaucoma. Ophthalmol Glaucoma. 2020;3:350-9.

1 Koh V, Chew P, Triolo G, et al. Treatment outcomes using the PAUL glaucoma implant to control intraocular pressure in eyes with refractory glaucoma. Ophthalmol Glaucoma. 2020;3:350-9.

2 Heuer DK, Barton K, Grehn F, et al. Consensus on definitions of success. In: Shaarawy TM, Sherwood MB, Grehn F, editors. Guidelines on Design and Reporting of Surgical Trials. World Glaucoma Association; 2008. p. 15-24.

Significant reductions in both IOP and Glaucoma medications used were observed after one year implanting of PAUL®.

The failure rate was 5%, the complete success rate was 69% and the qualified success rate was 93%.

INTERESTED IN FINDING OUT MORE OR
WISH TO COLLABORATE?​